أعرض في EDS

On the use of the healthy lifestyle index to investigate specific disease outcomes

التفاصيل البيبلوغرافية
العنوان: On the use of the healthy lifestyle index to investigate specific disease outcomes
المؤلفون: Viallon, Vivian, Freisling, Heinz, Matta, Komodo, Nannsen, Anne Østergaard, Dahm, Christina C., Tjønneland, Anne, Eriksen, Anne Kirstine, Kaaks, Rudolf, Katzke, Verena A., Schulze, Matthias B., Masala, Giovanna, Tagliabue, Giovanna, Simeon, Vittorio, Tumino, Rosario, Milani, Lorenzo, Derksen, Jeroen W. G., van der Schouw, Yvonne T., Nøst, Therese Haugdahl, Borch, Kristin Benjaminsen, Sandanger, Torkjel M., Quirós, J. Ramón, Rodriguez-Barranco, Miguel, Bonet, Catalina, Aizpurua-Atxega, Amaia, Cirera, Lluís, Guevara, Marcela, Sundström, Björn, 1968, Winkvist, Anna, Heath, Alicia K., Gunter, Marc J., Weiderpass, Elisabete, Johansson, Mattias, Ferrari, Pietro
المصدر: Scientific Reports. 14(1)
مصطلحات موضوعية: Cancer, Cardiovascular diseases, Composite score, Healthy lifestyle index, Lifestyle factors, Mortality, Type 2 diabetes
الوصف: The healthy lifestyle index (HLI), defined as the unweighted sum of individual lifestyle components, was used to investigate the combined role of lifestyle factors on health-related outcomes. We introduced weighted outcome-specific versions of the HLI, where individual lifestyle components were weighted according to their associations with disease outcomes. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we examined the association between the standard and the outcome-specific HLIs and the risk of T2D, CVD, cancer, and all-cause premature mortality. Estimates of the hazard ratios (HRs), the Harrell’s C-index and the population attributable fractions (PAFs) were compared. For T2D, the HR for 1-SD increase of the standard and T2D-specific HLI were 0.66 (95% CI: 0.64, 0.67) and 0.43 (0.42, 0.44), respectively, and the C-index were 0.63 (0.62, 0.64) and 0.72 (0.72, 0.73). Similar, yet less pronounced differences in HR and C-index were observed for standard and outcome-specific estimates for cancer, CVD and all-cause mortality. PAF estimates for mortality before age 80 were 57% (55%, 58%) and 33% (32%, 34%) for standard and mortality-specific HLI, respectively. The use of outcome-specific HLI could improve the assessment of the role of lifestyle factors on disease outcomes, thus enhancing the definition of public health recommendations.
وصف الملف: electronic
URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-227963
https://doi.org/10.1038/s41598-024-66772-w
https://umu.diva-portal.org/smash/get/diva2:1885605/FULLTEXT01.pdf
قاعدة البيانات: SwePub
الوصف
تدمد:20452322
DOI:10.1038/s41598-024-66772-w